Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S I Bearman

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Bone Marrow Transplantation|September 12, 2001
Avoiding hepatic veno-occlusive disease: what do we know and where are we going?S I Bearman
Blood|June 1, 1995
The syndrome of hepatic veno-occlusive disease after marrow transplantationS I Bearman
Current Opinion in Hematology|May 1, 1997
Use of stem cell factor to mobilize hematopoietic progenitorsS I Bearman
Current Opinion in Oncology|April 6, 2000
Veno-occlusive disease of the liverS I Bearman
Leukemia & Lymphoma|December 30, 1998
Prevention and treatment of hepatic venocclusive disease after high-dose cytoreductive therapyP Richardson, S I Bearman
Blood|June 1, 1979
Effects of oxygen tension and pH on the respiratory burst of human neutrophilsT G Gabig, S I Bearman, B M Babior
The Journal of Biological Chemistry|August 15, 1987
Intracellular localization of lactosylceramide, the major human neutrophil glycosphingolipidF W Symington, W A Murray, S I Bearman, et al.
Hematology/Oncology Clinics of North America|June 1, 1993
Role of autotransplantation in treatment of other solid tumorsE J Shpall, S M Stemmer, S I Bearman, et al.
Gynecologic Oncology|September 1, 1994
Future strategies for the treatment of advanced epithelial ovarian cancer using high-dose chemotherapy and autologous bone marrow supportE J Shpall, R B Jones, S I Bearman, et al.
Blood|November 15, 1992
Recombinant human tissue plasminogen activator for the treatment of established severe venocclusive disease of the liver after bone marrow transplantationS I Bearman, M C Shuhart, M S Hinds, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Bone Marrow Transplantation|September 12, 2001
Avoiding hepatic veno-occlusive disease: what do we know and where are we going?S I Bearman
Blood|June 1, 1995
The syndrome of hepatic veno-occlusive disease after marrow transplantationS I Bearman
Current Opinion in Hematology|May 1, 1997
Use of stem cell factor to mobilize hematopoietic progenitorsS I Bearman
Current Opinion in Oncology|April 6, 2000
Veno-occlusive disease of the liverS I Bearman
Leukemia & Lymphoma|December 30, 1998
Prevention and treatment of hepatic venocclusive disease after high-dose cytoreductive therapyP Richardson, S I Bearman
Blood|June 1, 1979
Effects of oxygen tension and pH on the respiratory burst of human neutrophilsT G Gabig, S I Bearman, B M Babior
The Journal of Biological Chemistry|August 15, 1987
Intracellular localization of lactosylceramide, the major human neutrophil glycosphingolipidF W Symington, W A Murray, S I Bearman, et al.
Hematology/Oncology Clinics of North America|June 1, 1993
Role of autotransplantation in treatment of other solid tumorsE J Shpall, S M Stemmer, S I Bearman, et al.
Gynecologic Oncology|September 1, 1994
Future strategies for the treatment of advanced epithelial ovarian cancer using high-dose chemotherapy and autologous bone marrow supportE J Shpall, R B Jones, S I Bearman, et al.
Blood|November 15, 1992
Recombinant human tissue plasminogen activator for the treatment of established severe venocclusive disease of the liver after bone marrow transplantationS I Bearman, M C Shuhart, M S Hinds, et al.
Pageof 7